A molecular journey on the pathogenesis of primary hyperoxaluria.
| Autor: | Cellini B; Department of Medicine and Surgery, University of Perugia, Perugia, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current opinion in nephrology and hypertension [Curr Opin Nephrol Hypertens] 2024 Jul 01; Vol. 33 (4), pp. 398-404. Date of Electronic Publication: 2024 Apr 11. |
| DOI: | 10.1097/MNH.0000000000000987 |
| Abstrakt: | Purpose of Review: Primary hyperoxalurias (PHs) are rare disorders caused by the deficit of liver enzymes involved in glyoxylate metabolism. Their main hallmark is the increased excretion of oxalate leading to the deposition of calcium oxalate stones in the urinary tract. This review describes the molecular aspects of PHs and their relevance for the clinical management of patients. Recent Findings: Recently, the study of PHs pathogenesis has received great attention. The development of novel in vitro and in vivo models has allowed to elucidate how inherited mutations lead to enzyme deficit, as well as to confirm the pathogenicity of newly-identified mutations. In addition, a better knowledge of the metabolic consequences in disorders of liver glyoxylate detoxification has been crucial to identify the key players in liver oxalate production, thus leading to the identification and validation of new drug targets. Summary: The research on PHs at basic, translational and clinical level has improved our knowledge on the critical factors that modulate disease severity and the response to the available treatments, leading to the development of new drugs, either in preclinical stage or, very recently, approved for patient treatment. (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|